GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a prominent focus in therapeutic studies, largely due to its notable impact on managing diseases such as adult-onset diabetes and excess body fat. New trials have shown that more than glucose regulation, GLP-1 drugs offer promise for circulatory function and even bra